Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Prostate Stage II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03412396
What this trial is testing

Apalutamide in Treating Patients With Prostate Cancer Before Radical Prostatectomy

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate Cancer AJCC v8
M.D. Anderson Cancer Center 45
Testing effectiveness (Phase 2)Study completedNCT03570827
What this trial is testing

Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8+3 more
Mayo Clinic 53
Testing effectiveness (Phase 2)Study completedNCT00939510
What this trial is testing

Lenalidomide and GM-CSF in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Robert Dreicer MD 32
Not applicableUnknownNCT01562223
What this trial is testing

Studying Repeated DCE-MRI and DWI in Patients Diagnosed With Prostate Cancer

Who this might be right for
Prostate Cancer
American College of Radiology Imaging Network 30
Testing effectiveness (Phase 2)Study completedNCT00031889
What this trial is testing

Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer

Who this might be right for
Prostate Cancer
Swiss Cancer Institute 5
Testing effectiveness (Phase 2)Ended earlyNCT01200810
What this trial is testing

Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Study completedNCT00016913
What this trial is testing

Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 34
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Testing effectiveness (Phase 2)Study completedNCT03693612
What this trial is testing

GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 26
Not applicableStudy completedNCT01992016
What this trial is testing

A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine

Who this might be right for
Adenocarcinoma of the ProstateBone MetastasesSoft Tissue Metastases+4 more
University of Colorado, Denver 11
Testing effectiveness (Phase 2)Study completedNCT00032006
What this trial is testing

Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 48
Testing effectiveness (Phase 2)Study completedNCT00016393
What this trial is testing

BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
SWOG Cancer Research Network
Large-scale testing (Phase 3)Study completedNCT00931528
What this trial is testing

Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy

Who this might be right for
Prostate CancerSexual Dysfunction
Radiation Therapy Oncology Group 242
Testing effectiveness (Phase 2)WithdrawnNCT00003622
What this trial is testing

Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy

Who this might be right for
Prostate Cancer
James Ahlgren
Not applicableStudy completedNCT02600156
What this trial is testing

Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors

Who this might be right for
Prostate CancerProstate AdenocarcinomaStage I Prostate Cancer AJCC v8+2 more
Mayo Clinic 7
Testing effectiveness (Phase 2)Ended earlyNCT00483561
What this trial is testing

Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
University of Nebraska 26
Testing effectiveness (Phase 2)UnknownNCT06221774
What this trial is testing

Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors

Who this might be right for
Clear Cell Renal CarcinomaUrothelial CarcinomaMetastatic Castration-resistant Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 42
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Testing effectiveness (Phase 2)Looking for participantsNCT03866382
What this trial is testing

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Who this might be right for
Bladder AdenocarcinomaBladder Clear Cell AdenocarcinomaBladder Mixed Adenocarcinoma+42 more
National Cancer Institute (NCI) 314
Testing effectiveness (Phase 2)Study completedNCT00078923
What this trial is testing

Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 32
Next Page